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Signaling via the Pyk2-Src-Cbl complex downstream of integrins contributes to the assembly, organization,
and dynamics of podosomes, which are the transient adhesion complexes of highly motile cells such as
osteoclasts and dendritic cells. We previously demonstrated that the GTPase dynamin is associated with
podosomes, regulates actin flux in podosomes, and promotes bone resorption by osteoclasts. We report here
that dynamin associates with Pyk2, independent of dynamin’s GTPase activity, and reduces Pyk2 Y402
phosphorylation in a GTPase-dependent manner, leading to decreased Src binding to Pyk2. Overexpressing
dynamin decreased the macrophage colony-stimulating factor- and adhesion-induced phosphorylation of Pyk2
in osteoclastlike cells, suggesting that dynamin is likely to regulate Src-Pyk2 binding downstream of integrins
and growth factor receptors with important cellular consequences. Furthermore, catalytically active Src
promotes dynamin-Pyk2 association, and mutating specific Src-phosphorylated tyrosine residues in dynamin
blunts the dynamin-induced decrease in Pyk2 phosphorylation. Thus, since Src binds to Pyk2 through its
interaction with phospho-Y402, our results suggest that Src activates a negative-feedback loop downstream of
integrin engagement and other stimuli by promoting both the binding of dynamin to Pyk2-containing com-
plexes and the dynamin-dependent decrease in Pyk2 Y402 phosphorylation, ultimately leading to the dissoci-
ation of Src from Pyk2.
Podosomes are specialized transient actin-containing adhe-
sion structures (11, 14, 37, 60) that are found in highly motile
cells, such as osteoclasts, macrophages, dendritic cells, trans-
formed metastatic cells, and v-src-transformed cells (37, 43),
where they are thought to play important roles in cellular
migration and invasion (34). In resorbing osteoclasts on bone,
podosomes are concentrated within the sealing zone, a beltlike
actin-rich structure that is important for adhesion and which
delineates the resorptive region of the cell known as the ruffled
border. Unlike focal adhesions, which are relatively stable
structures (11, 60), the assembly and disassembly of podo-
somes occurs within minutes (t1/2  2 to 4 min) and involves
the recruitment and activation of integrins, signaling proteins
and scaffolding proteins (11, 14, 35, 47, 60). However, the
mechanisms of action of key signaling proteins involved in
podosome assembly and disassembly are only partially under-
stood.
The focal adhesion kinase Pyk2 has been linked to the pro-
liferation, migration, and activity of a variety of mesenchymal,
epithelial, and hematopoietic cell types. Several groups, includ-
ing our own, have reported the importance of Pyk2 in podo-
some belt organization, cell spreading, and bone-resorbing ac-
tivity in osteoclasts (18, 26, 31, 40, 65, 66). Pyk2 is recruited to
activated 2 and 3 integrins (9, 20) at adhesion sites and is
autophosphorylated at Y402 (17, 47, 50) via an intermolecular
trans-acting mechanism (46). Although Pyk2 is partially acti-
vated by integrin-induced Ca2 signaling (20, 50), the induc-
tion of Pyk2’s full catalytic activity requires the binding of Src
via its SH2 domain to autophosphorylated Pyk2 Y402 and the
subsequent phosphorylation of Pyk2 at functionally distinct
sites, including Y579, Y580, and Y881 (17, 31, 46). The binding
of Src to phosphorylated Pyk2, which leads to the formation of
a multiprotein signaling complex at adhesion sites (17, 40, 50),
is critical for Pyk2 activity, as demonstrated by the fact that
Pyk2 phosphorylation and activity are significantly reduced in
osteoclasts derived from Src/ mice (17, 40). Src/ osteo-
clasts also exhibit decreased motility (50) and decreased bone-
resorbing activity (40, 54, 59), and we recently demonstrated
that Src promotes both podosome formation and disassem-
bly, as well as actin flux into existing podosomes and the
organization of podosomes into a peripheral belt in osteo-
clasts (15).
We have also demonstrated that the GTP-hydrolyzing pro-
tein dynamin-2, which is ubiquitously expressed and well
known for its role in endocytosis (53), regulates actin remod-
eling in the podosomes of osteoclasts and Rous sarcoma virus-
transformed baby hamster kidney cells (43). In addition, a
dynamin-2 mutant that binds GTP with reduced affinity
(dynK44A) (12) decreased the flux of actin into podosomes
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(43) and disrupted podosome belt formation in osteoclasts,
thereby affecting osteoclast migration and bone-resorbing ac-
tivity (8). The dynamin proteins, of which there are three
homologous isoforms (3), contain several protein domains: a
GTP-hydrolyzing domain (GTPase), a plextrin homology do-
main that mediates binding to phosphoinositides, a GTPase
effector domain (GED), and a C-terminal proline-rich domain
(PRD) (38, 45, 55) through which dynamin binds a number of
functionally diverse SH3-containing molecules, such as Src,
cortactin, Grb2, and N-Wasp (1, 7, 27, 39, 58). We previously
reported that dynamin-2 partially colocalizes and associates
with the E3-ubiquitin ligase Cbl within the podosome belt/
sealing zone of osteoclasts, as well as in SYF cells, which lack
the Src family kinases Src, Yes, and Fyn, and in HEK 293 cells
that stably express the vitronectin receptor (293VnR) (8). Pro-
tein complexes containing dynamin-2 and Cbl, which are both
substrates of Src (1, 2, 23, 50, 56), were disrupted in the pres-
ence of activated Src and stabilized in the absence of Src (8),
demonstrating a key role of Src in regulating the formation of
signaling complexes in osteoclasts downstream of integrins.
In the present study, we sought to determine whether dy-
namin, which regulates podosome actin dynamics and bone
resorption in osteoclasts, also associates with Pyk2 and/or reg-
ulates Pyk2’s activities in osteoclasts. We report here that dy-
namin associates with Pyk2 and promotes the dephosphoryla-
tion of Pyk2 Y402 and that catalytically active Src promotes
both dynamin’s association with Pyk2 and the dynamin-in-
duced dephosphorylation of Pyk2 Y402, resulting, in turn, in
the decreased binding of Src to Pyk2. Thus, we propose that
dynamin regulates podosome dynamics and osteoclast bone-
resorbing activity by promoting the disassembly of the Pyk2-
Src-Cbl complex that is formed in osteoclasts downstream of
3 integrin activation.
MATERIALS AND METHODS
Materials. Anti-dynamin-2 (dynamin II; epitope 274-555) and anti-Pyk2 anti-
bodies used for Western blot analyses were obtained from Transduction Labo-
ratories (Lexington, KY). Anti-human dynamin (hudy2), anti-avian Src and anti-
phosphotyrosine (clone 4G10) antibodies were purchased from Upstate
Biotechnology (Lake Placid, NY). Anti-Pyk2-phospho-Y402 and anti-Src-phos-
pho-Y416 antibodies were obtained from Biosource International. Polyclonal
and monoclonal anti-green fluorescent protein (anti-GFP) antibodies (Living
Colors) were from Clontech (Palo Alto, CA). Antihemagglutinin (anti-HA) was
from Bethyl Laboratories (Montgomery, TX). Horseradish peroxidase-con-
jugated anti-rabbit and anti-mouse secondary antibodies were obtained from
Fisher Scientific (Fairlawn, NJ). PP2, SU6656, and collagenase A were pur-
chased from Calbiochem (San Diego, CA). Orthovanadate was purchased from
Sigma-Aldrich (St. Louis, MO). Fluorescein-conjugated secondary antibodies
were from Molecular Probes (Eugene, OR). Collagen was obtained from Nitta
Gelatin Co. (Osaka, Japan).
Plasmids. A construct of rat dynamin-2 (splice variant aa) (10) and the dy-
namin-2 mutant dynK44A inserted into the pEGFP-N1 vector were generated as
previously described (3, 12). Dynamin-2 point mutations were generated by
site-directed mutagenesis (Stratagene, La Jolla, CA) with the following primer
combinations: dynY231F (5-CTT GAG AAG AGG CTT CAT CGG CGT GGT
TAAC and 5-GTT AAC CAC GCC GAT GAA GCC TCT TCT CAAG) and
dynY597F (5-CAG AGG AAC GTC TTC AAG GAC CTG CGAC and 5-GTC
GCA GGT CCT TGA AGA CGT TCC TCTG). The c-Src construct was pro-
vided by P. Schwartzberg (National Institutes of Health, Bethesda, MD).
pBK-SrcW118K and pBKSrcR175L constructs were made by site-directed mutagen-
esis as described elsewhere (15). Wild-type human Pyk2 cDNA was provided by
J. Schlessinger (Yale University, New Haven, CT). Full-length Pyk2 and Pyk2
point mutants Y402F and K457A were generated as previously described (16, 33,
57). Grb2-myc was provided by I. Dikic (Goethe University Medical School,
Frankfurt, Germany). DynPRD was kindly provided by P. De Camilli (Yale
University, New Haven, CT). Src-SH2–glutathione S-transferase (GST) and Src-
SH3-GST constructs were generated and prepared as previously described (51).
All cDNA mutations were confirmed by sequencing.
Transient transfections. Transient transfections were performed using
FuGENE 6 (Roche, Indianapolis, IN) according to the manufacturer’s specifications
using a total of 6 g of DNA and 12 l of FuGENE per 100-mm2 tissue culture
plate. In all experiments, the total amount of cDNA transfected was kept con-
stant by the addition of empty pcDNA3.1 vector. Transient transfections were
performed in 293VnR cells (HEK293 human embryonic kidney cells that stably
overexpress the v3 integrin/VnR, the major integrin found on osteoclasts), a
cell line that we have validated as a suitable model system and used extensively
to elucidate Pyk2-Src-Cbl intermolecular interactions (40, 50) and the interaction
of dynamin with Cbl (8). Transiently transfected cells were maintained in -min-
imal essential medium containing 10% fetal bovine serum (FBS) for 72 h after
transfection.
Coimmunoprecipitation assays. Coimmunoprecipitations were performed as
previously described (8, 50). Briefly, cells were lysed in modified radioimmuno-
precipitation assay buffer containing 50 mM Tris-Cl, 150 mM NaCl, 1% NP-40,
0.25% sodium deoxycholate, and protease and phosphatase inhibitors (1 mM
phenylmethylsulfonyl fluoride, 1 mM NaF, 1 mM sodium orthovanadate, and 10
g each of leupeptin, aprotinin, and pepstatin/ml). Lysates were sonicated and
the supernatant clarified by centrifugation. Because dynamin-2 is endogenously
expressed in 293VnR cells and in osteoclasts, transient transfections were per-
formed with GFP-tagged dynamin-2. Immunoprecipitations were performed
with a polyclonal antibody against GFP to distinguish between endogenous and
recombinant dynamin. Pyk2 is not expressed in 293VnR cells, and recombinant
Pyk2 was therefore immunoprecipitated with antibodies to Pyk2. Typically, 500
g of cell lysate protein was incubated with 5 g of primary antibody for 2 to 16 h
at 4°C. Immunoprecipitations were performed with protein G-agarose beads for
1 h. After binding and washing, ca. 80% of the target antigen protein remained
bound to the beads. The samples were heated to 100°C in sample buffer con-
taining sodium dodecyl sulfate (SDS) and -mercaptoethanol and resolved by
SDS-polyacrylamide gel electrophoresis (PAGE). For most samples, 100% of the
immune complex was loaded on the gels. However, in 293VnR experiments in
which Pyk2 was overexpressed in the absence of dynamin, only 30% of the
immunoprecipitated Pyk2 (Pyk2 control) was loaded onto gels due to the high
phosphorylation state of Pyk2 and the potential for Western blot saturation.
Total cell lysates (TCLs) (20 g) were also resolved alongside immunoprecipi-
tates and blotted as indicated. Western blot analysis was performed by using an
enhanced chemiluminescence detection kit (Amersham) with multiple exposure
times. The phospho-Y402 antibody was specific for Pyk2 as determined by
Western blot analysis of immunoprecipitated Pyk2 or the Pyk2-Y402F mutant
(see Fig. S1 in the supplemental material). After Western blotting, membranes
were stripped with a solution containing 6.25 mM Tris, 2% SDS (pH 6.7), and
0.07% -mercaptoethanol at 50°C for 40 min prior to reblotting. Films of West-
ern blots were scanned by using an Epson Stylus Photo RX100 printer/scanner,
and images were processed with Adobe Photoshop. All experiments were per-
formed a minimum of three times, and representative blots or images are shown.
A comparison of band intensity was performed by densitometric analysis using
Scion Image analysis software or ImageJ (National Institutes of Health free-
ware).
Preparation of authentic osteoclasts and OCLs. Authentic osteoclasts were
isolated from the long bones of 2- to 4-day-old neonatal mice. Bones were
dissected free of adherent tissues, placed in -minimal essential medium con-
taining 5% FBS, and minced into small pieces. After vigorous pipetting to release
osteoclasts, the bone particles were allowed to sediment, and the remaining cell
suspension containing osteoclasts was seeded onto serum-coated coverslips. For
all biochemical analyses (both coimmunoprecipitations and Western blots),
mouse osteoclastlike cells (OCLs) were used. OCLs were generated using the
murine coculture system (62) by culturing neonatal primary calvarial osteoblasts
with spleen and marrow cells in the presence of 1,25-dihyrodroxyvitamin D3 and
prostaglandin E2. After 4 to 5 days in culture, the osteoblast layer was removed
by gentle pipetting of medium over the surface of the cell layer, leaving purified
OCLs behind. Suspensions of serum-starved (1% FBS, 1 h) OCLs were obtained
by treating the purified OCLs with 10 mM EDTA for 5 min at 37°C. Cells were
then flushed off the culture dishes, washed once in serum-free medium, and then
resuspended in serum-free medium (63). For experiments involving macrophage
colony-stimulating factor (M-CSF) stimulation, bone marrow cells were plated
on collagen gel (41) and differentiated with M-CSF (20 ng/ml) and RANKL (100
ng/ml) for 7 days (61). For experiments examining the effects of activating
integrin signaling, OCLs generated by the coculture system were replated on
culture plates precoated with mouse vitronectin (25 g/ml for 2 h at 37°C). For
confocal studies after adenovirus infections, OCLs were generated by using the
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coculture method on collagen gel-coated dishes. Collagen was digested with
0.1% collagenase, and the cells were replated onto coverslips or dentin slices
after collagenase treatment. Animal protocols were approved by the Yale Uni-
versity Institutional Animal Care and Use Committee.
Confocal microscopy. Authentic osteoclasts and adenovirus-infected OCLs
were seeded onto FBS-coated coverslips and incubated for 2 to 24 h at 37°C
followed by fixing with 3.7% formaldehyde in phosphate-buffered saline for 10
min. Fixed cells were visualized by using a Zeiss 510 Meta laser scanning confocal
microscope. Coverslips for actin labeling were extracted in ice-cold acetone for
3 to 5 min, incubated in a 1:40 dilution of rhodamine phalloidin stock solution
(Molecular Probes) for 1 h, washed with phosphate-buffered saline, and mounted
in FluorSave (Calbiochem). All other coverslips were permeabilized in 0.05%
saponin for 30 min, blocked in 5% normal goat serum (Roche) for 30 min, and
then incubated in appropriate primary antibodies. Coverslips were then washed
again, incubated with fluorescent secondary antibody (Alexa Fluor 488, green;
Alexa Fluor 568, red; and Alexa Fluor 647, blue), washed again, and mounted in
FluorSave. Images were obtained at room temperature by using a Zeiss LSM 510
Meta laser scanning microscope with a	63 water immersion lens and Zeiss LSM
510 software. Images were recorded, composites were compiled, and total image
enhancements were performed using Adobe Photoshop 6.0 To quantify the effect
of dynamin protein levels of Pyk2 phosphorylation, multiple preparations of cells
were labeled and imaged by confocal microscopy using constant imaging param-
eters for time of exposure, light intensity, and magnification, and the relative
intensities were then determined.
Generation of recombinant adenovirus. Recombinant adenovirus expressing
dynamin-2 (ba splice variant) or the GTP-binding mutant dynamin-2 (dynK44A)
containing HA tags were made using the tetracycline-inhibited Cre-lox recom-
bination system as described elsewhere (13) and were kindly provided by S.
Schmid (Scripps Research Institute, La Jolla, CA). To express dynamin in OCLs,
adenoviruses expressing the tetracycline transcription activator (tTA; 20 l) and
dynamin-HA (0 to 400 l) were added in combination (3). Infection of mouse
OCLs with adenoviruses was performed on immature OCLs after 3 days in
culture. Cells were infected using a multiplicity of infection score of 100, which
results in a two- to threefold overexpression of dynamin relative to endogenous
dynamin. After infection, OCLs were either replated onto coverslips for 24 h and
processed for confocal immunofluorescence microscopy or harvested directly for
biochemical analyses.
Adenovirus vectors expressing dynamin-2 shRNA or scrambled shRNA (scb-
shRNA) were generated by using a Block-iT U6 RNAi entry vector kit and the
Block-iT adenoviral RNAi expression system (Invitrogen), according to the man-
ufacturer’s instructions. Dynamin-2 primers for shRNA generation were previ-
ously published (28). OCLs were infected with shRNA adenovirus (multiplicity
of infection of 100 to 300) for 3 days prior to harvesting. Protein depletion was
confirmed by Western blotting and confocal immunofluorescence.
RESULTS
Dynamin associates with Pyk2 in osteoclasts. We previously
demonstrated that dynamin partially colocalized with Cbl, Src,
and several actin-binding proteins in the peripheral podosome
belt of osteoclasts. We found that dynamin formed a protein
complex with Src and Cbl in osteoclasts as well as in 293VnR
cells, and that the interaction of dynamin with Cbl was nega-
tively regulated by Src’s kinase activity (8). Given these obser-
vations and our previous finding that the Pyk2-Src-Cbl complex
plays an important role in osteoclast function (50), we sought
to determine whether dynamin associates with Pyk2 and, if so,
what are the functional consequences of their interaction.
Consistent with previous reports (17, 26, 66), confocal im-
munofluorescence analysis of authentic osteoclasts showed the
presence of Pyk2 together with actin and dynamin in the
podosome belt (Fig. 1A, arrow), similar to what we reported for
Cbl (8), and at the cell periphery (arrowhead). Coimmunopre-
cipitation and Western blot analysis of OCL lysates revealed
that dynamin and Pyk2 formed a molecular complex in OCLs
(Fig. 1B), a finding consistent with the overlapping expression
of these proteins in the podosome belt. Since Pyk2 is activated
in osteoclasts by the engagement of integrins (20, 50), we
examined whether the association of Pyk2 and dynamin was
altered by activating the v3 integrin (VnR). There was little
difference in the association of dynamin with Pyk2 in OCLs
that were kept in suspension and then replated on vitronectin
for up to 3 h (Fig. 1C), suggesting that the association of
dynamin and Pyk2 was not dependent on the activation of
the VnR.
Dynamin decreases Pyk2 Y402 phosphorylation. The inter-
action of dynamin with some of its binding partners is regu-
lated by GTP binding and activity (53), while the interaction of
Pyk2 with its downstream effectors is modulated by Pyk2’s
catalytic activity and the phosphorylation of its tyrosine resi-
dues (4). We therefore examined whether dynamin’s GTPase
activity affected dynamin’s association with Pyk2, using the
dynK44A mutant (12), and also compared the binding of wild-
type Pyk2, the autophosphorylation site mutant (Pyk2-Y402F)
and kinase-inactive Pyk2 (Pyk2-K457A) to the two dynamin
proteins (see Fig. S2 in the supplemental material). Similar
amounts of wild-type dynamin and dynK44A coimmunopre-
cipitated with all three Pyk2 variants, suggesting that neither
dynamin’s GTPase activity nor Pyk2’s catalytic activity and
phosphorylation at Y402 are critical for the dynamin-Pyk2
association. Together, these findings are consistent with the
observation that dynamin’s association with Pyk2 in OCLs ap-
peared to be independent of the engagement of the VnR (Fig.
1C), which leads to Y402 phosphorylation and Pyk2 activation
(20, 50).
We next examined whether dynamin was phosphorylated by
Pyk2. 293VnR cells were cotransfected with Pyk2 and either
dynamin-GFP or dynK44A-GFP. The GFP-tagged dynamin
proteins were immunoprecipitated, and the protein complexes
were subjected to Western blot analysis to detect phosphoty-
rosine. The phosphorylation of both wild-type dynamin and
dynK44A was detected in the presence but not in the absence
of cotransfected Pyk2. Interestingly, the overall phosphoryla-
tion of wild-type dynamin was significantly less than that of
dynK44A (Fig. 2A). We therefore examined whether the phos-
phorylation of Pyk2, which correlates with Pyk2 activity (46),
was lower when dynamin was overexpressed (Fig. 2B). Both
wild-type dynamin and dynK44A dose dependently reduced
the total tyrosine phosphorylation of Pyk2 (blot 1) and the
phosphorylation of the autophosphorylated Y402 (blot 2), with
wild-type dynamin having a greater effect with equivalent
amounts of transfected cDNA (arrows). The reduced effect of
the GTPase-deficient dynK44A suggested that the dynamin-
induced decrease in Pyk2 phosphorylation was at least partly
dependent on dynamin’s GTPase activity.
We next sought to determine whether endogenous dynamin
affected the function of Pyk2 in osteoclasts. We first examined
the effect of reducing endogenous dynamin levels in OCLs
using adenovirus-expressed dynamin-2 shRNA (dyn-shRNA).
Western blots showed that the dynamin-2 shRNA, but not the
control scrambled shRNA (scb-shRNA), significantly reduced
dynamin levels in OCLs (Fig. 3A, blot 3). Furthermore, West-
ern blot analysis showed that the level of phospho-Y402 was
increased in the dyn-shRNA-infected OCLs (Fig. 3A, blot 1).
The decrease in dynamin protein expression by dyn-shRNA
was also observed by confocal immunofluorescence micros-
copy (Fig. 3Bg, l, and q). In OCLs infected with the control
scb-shRNA (Fig. 3Bu to y), the peripheral podosome belt
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appeared similar to uninfected OCLs (Fig. 3Ba to e), whereas
the podosome belt in the dyn-shRNA-infected OCLs (Fig. 3Bf
to t) was considerably wider than control cells, an effect similar
to what was seen in OCLs that overexpress dynK44A (8). The
actin belt matures by the disassembly of podosomes at the
center of the cell and the assembly of podosomes at the cell
periphery (14). Therefore, we hypothesize that podosome dis-
assembly and the maturation of the actin belt is disrupted in
the dyn-shRNA-infected cells.
In the untreated OCLs and scb-shRNA-infected OCLs,
Pyk2 was enriched in the podosome belt and present at lower
levels in the central part of the cells (Fig. 3Bc and w). In
contrast, Pyk2 in the dyn-shRNA-infected OCLs (Fig. 3Bh, m,
and r) partially relocalized away from the cell periphery, and
the enrichment of Pyk2 in the belt was often not observed. The
level of phosphorylated Pyk2 Y402 appeared to be higher in
the dyn-shRNA-infected OCLs (Fig. 3Bj, o, and t) than in
control (Fig. 3Be) or scb-shRNA-infected cells (Fig. 3By), par-
ticularly in the centrally located actin patches (arrows). Quan-
tification of the phosphorylated Pyk2-Y402 and Pyk2 fluores-
cence intensities revealed that phospho-Y402, normalized to
Pyk2, increased by 40% in the dyn-shRNA-infected OCLs
(Fig. 3C), indicating that dynamin indeed downregulates Pyk2
phosphorylation in osteoclasts.
Pyk2 phosphorylation is increased in osteoclasts by the cy-
tokine M-CSF or by the engagement of 2 and 3 integrins (19,
20, 31, 40, 50). We therefore examined the effect of overex-
pressing dynamin on the stimulus-induced increases in Pyk2
phosphorylation in OCLs. OCLs were infected with either a
control adenovirus or an adenovirus encoding wild-type dy-
namin (dyn-HA) and then treated with M-CSF or vehicle. As
shown in Fig. 4A, M-CSF treatment of the control-infected
OCLs increased the width of the actin-rich podosome belt/
sealing zone (compare Fig. 4Ab and f) and significantly in-
creased the phosphorylation of Pyk2 Y402, particularly in the
podosome belt/sealing zone (compare Fig. 4Ac and g). In con-
trast, Pyk2 Y402 phosphorylation remained low in M-CSF-
treated dynamin-HA adenovirus-infected OCLs (Fig. 4Ak).
FIG. 1. Dynamin and Pyk2 colocalize within the actin podosome belt and form a molecular complex in osteoclasts. (A) Confocal immuno-
fluorescence microscopy of authentic mouse osteoclasts plated on glass and labeled for Pyk2 (blue), dynamin (green), and actin (rhodamine-
phalloidin; red). Images from the three fluorescence channels were merged using Adobe Photoshop 6.0. The yellow arrow indicates overlapping
expression of dynamin, actin, and Pyk2 within the podosome belt, while the arrowhead shows peripherally localized Pyk2. Also shown are
high-magnification images showing the colocalization of Pyk2 with actin, dynamin with actin, and Pyk2 with dynamin. Scale bars, 5 m.
(B) Dynamin was immunoprecipitated from mouse OCLs and resolved by SDS-PAGE. Western blotting was performed with an anti-Pyk2
antibody. As a control for nonspecific binding, immunoprecipitations were also performed using an isotype-matched immunoglobulin G (IgG).
TCLs were blotted for dynamin or Pyk2. Reciprocal experiments in which the anti-Pyk2 antibody was used for immunoprecipitation and the
dynamin antibody was used for blotting were also performed, with similar results (data not shown). (C) OCLs were removed from the plates as
described in Materials and Methods and kept in suspension in medium supplemented with 1% FBS for 1 h. An equal number of cells was replated
onto culture plates previously coated with vitronectin and allowed to reattach for 0, 1, or 3 h. A total of 500 g of cell lysates were subjected to
immunoprecipitation as indicated. Immune complexes were resolved by SDS-PAGE and blotted as indicated. Portions (10 g) of TCLs were
blotted for dynamin or Pyk2. Molecular mass markers are indicated. Protein bands were quantified by densitometry. Numbers are in arbitrary units
and reflect the normalized ratios of band intensity in blot 1 (top, IP:Dyn/B:Pyk2) to blot 2 (middle, TCLs blotted for dynamin). Total Pyk2 levels
were not significantly changed by replating (blot 3, bottom). Similar results were obtained when immunoprecipitations were performed with an
anti-Pyk2 antibody, followed by blotting for endogenous dynamin (data not shown). Labels: IP, immunoprecipitation; B, Western blot; Dyn,
dynamin.
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We also observed a thinning of the podosome belt in the
dynamin-overexpressing OCLs (Fig.4Aj) as previously re-
ported (8). Quantification of the fluorescence intensities of
phospho-Y402 and Pyk2 in double-labeled OCLs confirmed
that the amount of phosphorylated Y402, normalized to Pyk2,
was significantly lower in the M-CSF-treated dynamin-HA-
infected cells relative to M-CSF-treated control-infected cells
(Fig. 4B). Immunoprecipitation studies confirmed that M-CSF
treatment increased Pyk2 phosphorylation in control OCLs
and provided additional evidence that overexpression of dy-
namin prevented the M-CSF-induced increase in Pyk2 phos-
phorylation (Fig. 4C). Furthermore, treating the dynamin-
overexpressing OCLs with the broad-spectrum tyrosine
phosphatase inhibitor orthovanadate prevented the dynamin-
induced decrease in Pyk2 phosphorylation, indicating that an
unidentified protein tyrosine phosphatase, possibly PTP-PEST
(36), contributes to the decrease in Pyk2 phosphorylation that
is induced by dynamin.
Finally, we examined the effect of dynamin on the attach-
ment-induced increase in Pyk2 phosphorylation in OCLs.
OCLs infected with either the dyn-HA adenovirus or the con-
trol adenovirus were kept in suspension and then replated for
1 h on vitronectin-coated plates to activate the VnR. The
tyrosine phosphorylation of Pyk2 was then examined by West-
ern blotting (Fig. 4D). As previously shown (50), Pyk2 phos-
phorylation was increased by replating control OCLs on vitro-
nectin. However, in the OCLs that overexpressed dynamin,
replating for 1 h failed to increase Pyk2 phosphorylation (Fig.
4D, arrow), suggesting that dynamin decreases integrin-in-
duced Pyk2 phosphorylation.
Taken together, these results indicate that dynamin down-
regulates Pyk2 Y402 phosphorylation in osteoclasts, both un-
der basal conditions and following physiologically important
stimuli that activate Pyk2. Furthermore, these findings support
the functional importance of the dynamin-Pyk2 interaction in
the context of the regulation of osteoclast function.
The dynamin-induced decrease in Pyk2 Y402 phosphoryla-
tion reduces Pyk2-Src binding. Src binds to phosphorylated
Pyk2 Y402 and phosphorylates other functionally important
Pyk2 tyrosine residues (16, 40, 46, 50, 52). Therefore, we pre-
dicted that the dynamin-induced decrease in Pyk2 Y402 phos-
phorylation would also reduce the binding of Src to Pyk2 and
the Src-catalyzed phosphorylation of Pyk2. To test this, dy-
namin or dynK44A were coexpressed with Pyk2 and either
wild-type Src or kinase-inactive SrcK295M in 293VnR cells,
and Pyk2-Src association was analyzed (Fig. 5). In the absence
of transfected dynamin, both wild-type Src and SrcK295M
bound to Pyk2 (Fig. 5, blot 1 [i.e., the top immunoprecipitation
FIG. 2. Dynamin reduces phosphorylation of Pyk2-Y402. (A) 293VnR cells were transiently cotransfected with Pyk2 and either dyn-GFP or
dynK44A-GFP. Dynamin and dynK44A were immunoprecipitated with anti-GFP and resolved by SDS-PAGE, and Western blot analysis was
performed with an antiphosphotyrosine (anti-pTyr) antibody. Immunoprecipitates were reblotted for dyn-GFP with anti-GFP, while TCLs were
blotted for Pyk2. Representative blots of 10 independent experiments are shown. (B) Increasing amounts of dyn-GFP (1 and 2 g) or
dynK44A-GFP cDNA (2 and 3 g) were transiently cotransfected with constant amounts of Pyk2 cDNA (3 g) into 293VnR cells. Empty vector
was used to keep total transfected cDNA constant. Immunoprecipitation of Pyk2 was performed, followed by SDS-PAGE. Western blot analyses
of immunoprecipitates, followed by stripping and reblotting was performed consecutively with an anti-pTyr), an anti-Pyk2-phospho-Y402 (pY402),
and an anti-Pyk2 antibody. Transiently expressed Pyk2 undergoes robust phosphorylation in the absence of dynamin proteins (lane 5) (30% of the
immunoprecipitate was loaded). However, coexpression of wild-type dynamin (lanes 1 and 2) or mutant dynamin (lanes 3 and 4) caused a
dose-dependent decrease in total phosphorylated Pyk2 (blot 1, top) and phosphorylated Pyk2-Y402 (blot 2, bottom). Dynamin reduced Pyk2
phosphorylation to a greater degree than dynK44A when similar amounts of cDNA were transfected (arrows). Representative blots from five
independent experiments are shown. Molecular mass markers are indicated. Labels: IP, immunoprecipitation; B, Western blot; Dyn, dynamin.
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FIG. 3. Dyn-shRNA increases Pyk2 Y402 phosphorylation in OCLs. (A) OCLs were prepared as described in Materials and Methods and were
left uninfected or were infected with dyn-shRNA or scrambled (scb)-shRNA adenoviruses. Cell lysates were resolved by SDS-PAGE and blotted
with antibodies to phospho-Pyk2-Y402, Pyk2 or dynamin. (B) OCLs were uninfected (a to e) or infected with adenoviruses expressing shRNA to
dynamin-2 (dyn-shRNA) (f to t) or a scrambled sequence (scb-shRNA) (u to y) for 3 days. Infected cells were replated on glass coverslips for 24 h,
fixed, and immunolabeled for dynamin, Pyk2, phosphorylated Pyk2-Y402, or actin (rhodamine phalloidin, red) as indicated. Cells were visualized
by scanning confocal immunofluorescence microscopy. Scale bars, 20 m. Experiments were repeated at least three times and representative cell
images are shown. The cells shown in panels f to j, k to o, and p to t are separate representative images of dyn-shRNA-infected cells. Arrows
indicate increased levels of phospho-Y402 in dyn-shRNA-infected cells. (C) The change in the phosphorylation of Pyk2 Y402 in dyn-shRNA-
infected OCLs was determined by normalizing the fluorescence intensity of anti-phospho-Y402 staining to the fluorescence intensity of anti-Pyk2
staining in double-labeled dyn-shRNA-infected OCLs. The fluorescence intensity of a minimum of seven cells from three different experiments was
measured (error bars represent the standard error of the mean [SEM]; *, P 
 0.05 [Student t test]). The specificity of the phospho-Y402 antibody
for Pyk2 that was used for labeling the OCLs was confirmed by Western blot analysis of Pyk2 and Pyk2-Y402F expressed in 293VnR cells (see Fig.
S1 in the supplemental material). Dyn, dynamin.
VOL. 29, 2009 DYNAMIN REDUCES Pyk2 PHOSPHORYLATION AND Src BINDING 3649
 o
n
 January 28, 2014 by Ruth Lilly M
edical Library
http://m
cb.asm
.org/
D
ow
nloaded from
 
blot], lanes 3 and 6). The Y402F mutation abolished the inter-
action of Pyk2 and Src (Fig. 5, blot 1, lane 9) and, as a conse-
quence, nearly eliminated the tyrosine phosphorylation of
Pyk2 (Fig. 5, blot 2 [i.e., the middle immunoprecipitation blot],
lane 9), confirming this important function of Y402 (46). Total
Pyk2 phosphorylation was markedly decreased when catalyti-
cally inactive SrcK295M was coexpressed, notwithstanding the
fact that more SrcK295M bound to Pyk2, confirming the re-
ported Src-catalyzed phosphorylation of Pyk2 (46). As pre-
dicted, the Pyk2-Src complex (blot 1, arrows) and Pyk2’s phos-
phorylation (Fig. 5, blot 2, arrows) were significantly reduced
when dynamin was also coexpressed. dynK44A had less of an
effect on both the association of Src with Pyk2 (Fig. 5, top
immunoprecipitation blot, lane 2) and the total phosphoryla-
tion of Pyk2 (Fig. 5, middle immunoprecipitation blot, lane 2),
a finding consistent with its more limited ability to reduce Pyk2
Y402 phosphorylation. Together, these results indicate that
dynamin reduces Pyk2-Src complex formation, possibly as a
consequence of decreasing Pyk2 Y402 phosphorylation.
Since Src catalyzes the phosphorylation of Y579 and Y580
within Pyk2’s catalytic domain and Y881 within its C-terminal
domain once it binds to phosphorylated Y402 (52), the dy-
namin-induced decrease in Src binding should reduce the
phosphorylation of these functionally important Pyk2 tyrosine
FIG. 4. Dynamin decreases stimulus-induced Pyk2 phosphorylation. (A) OCLs were generated on collagen with M-CSF and RANKL (see
Materials and Methods) and infected with control adenovirus (tTA) (a to h) or adenovirus expressing dyn-HA (i to l) for 3 days. Mature OCLs
were lifted by digestion with collagenase and replated onto dentin slices in the presence or absence of 50 g of M-CSF/ml. Cells were incubated
for 1 h prior to fixing and labeling. Exogenous dynamin expression was detected with anti-HA (blue). Actin was labeled with rhodamine-phalloidin
(red), and phosphorylated Pyk2-Y402 was labeled with an anti-phospho-Y402 antibody (green). Scale bars, 10 m. (B) The decrease in Pyk2 Y402
phosphorylation in the presence of overexpressed dyn-HA was quantified as in Fig. 3. Experiments were repeated three times, and error bars
represent the SEM. (C) OCLs infected with dyn-HA expressing adenovirus or a control virus (tTA) were serum starved for 30 min and then
stimulated with M-CSF for 1 h prior to harvesting and lysis. Alternatively, OCLs were treated with 4 mM orthovanadate (Ortho) for 1 h prior to
harvesting. Pyk2 was immunoprecipitated and analyzed for phosphotyrosine by Western blotting. The membranes were then stripped and reblotted
for total Pyk2. TCLs were blotted with an anti-HA antibody to detect adenovirus-expressed dyn-HA. Similar results were obtained in duplicate
experiments. (D) OCLs were infected with an adenovirus expressing dyn-HA or a control virus (tTA) for 3 days. After removal of osteoblasts,
mature OCLs were detached with trypsin-EDTA, washed and kept in suspension in serum-free media for 60 min and were either replated on plates
coated with mouse vitronectin and harvested immediately (0 h) or allowed to attach for 1 h. Immunoprecipitations were performed with an
anti-Pyk2 antibody, followed by Western blot analysis with an anti-pTyr antibody. Blots were stripped and blotted for Pyk2. TCLs were blotted with
an anti-HA antibody to detected adenovirus-expressed dyn-HA. Similar results were obtained in duplicate experiments. Labels: IP, immunopre-
cipitation; B, Western blot; Dyn, dynamin.
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residues. Analysis of immunoprecipitated Pyk2 with site-spe-
cific antibodies revealed that the phosphorylation of Pyk2
Y579, Y580, and Y881 were indeed decreased when dynamin
and Pyk2 were overexpressed in 293VnR cells (Fig. 6A).
dynK44A also decreased Pyk2 phosphorylation at all three
sites, but to a lesser extent than wild-type dynamin. The de-
creased phosphorylation of the catalytically important Y579
and Y580 would reduce the Pyk2 kinase activity (36, 46, 52),
possibly explaining the decreased tyrosine phosphorylation of
dynamin relative to the dynK44A that we initially observed. On
the other hand, phosphorylated Pyk2 Y881 is a known binding
site for the signaling proteins Grb2 (22) and c-Abl (67), and we
found that overexpression of dynamin in 293VnR cells also
decreased Grb2 binding to Pyk2 (Fig. 6B), a finding consistent
with the decreased phosphorylation of Y881. Thus, the dy-
namin-induced reduction of Pyk2 Y402 phosphorylation po-
tentially affects both Pyk2’s kinase activity and its subsequent
binding to downstream effector proteins, further supporting a
functional importance of the dynamin-Pyk2 association.
Src promotes the association of dynamin and Pyk2 and
dynamin-induced Pyk2 dephosphorylation. Eliminating the
binding of Src to Pyk2 by mutating Pyk2 Y402 and inhibiting
Src catalytic activity decreased the amount of Pyk2-associated
dynamin in 293VnR cells (Fig. 5 and Fig. S3 in the supplemen-
tal material, respectively), suggesting that Src might promote
Pyk2-dynamin association. We also observed that Pyk2-associ-
ated dynamin was reduced in OCLs lacking Src (Src/) (Fig.
7A), further supporting such a role for Src.
The association of Pyk2 and dynamin could involve either
the catalytic activity or the adaptor function of Src or both. We
first examined how Src’s kinase activity affected dynamin-Pyk2
association and the phosphorylation of Pyk2 Y402. We found
that inhibiting Src catalytic activity, using two Src family kinase
inhibitors (PP2 and SU6656) with different patterns of inhibi-
tory effects on non-Src family kinases (5), increased the phos-
phorylation of Pyk2 Y402 in OCLs (Fig. 7B), indicating that
Src-catalyzed phosphorylation indeed promotes the dynamin-
induced dephosphorylation of Py2 Y402.
Src-catalyzed phosphorylation of dynamin-1 on tyrosine res-
idues Y231 and Y597, which are conserved in dynamin-2, in-
creases dynamin’s GTPase activity (1, 2, 56). Our observations
that reducing dynamin’s GTPase activity partially disabled dy-
namin’s ability to induce Pyk2 Y402 dephosphorylation (Fig.
2B) and that Src’s catalytic activity promoted the association
of dynamin and Pyk2 raised the possibility that the Src-
catalyzed phosphorylation of dynamin might promote dy-
namin’s ability to decrease Pyk2 phosphorylation. To test
this, we mutated the Src-phosphorylated Y231 and Y597
FIG. 5. Dynamin reduces the binding of Pyk2 to Src. 293VnR cells
were cotransfected with empty vector, dyn-GFP, or dynK44A-GFP in
combination with Pyk2 or Pyk2-Y402F, as well as wild-type c-Src or
kinase-inactive SrcK295M as indicated. Immunoprecipitation and
Western blots were performed as indicated. Transfected dynamin was
detected with an anti-GFP antibody. The dynamin-mediated decrease
in Pyk2 phosphorylation (blot 2 [middle immunoprecipitation], ar-
rows) was accompanied by a corresponding loss in Src-Pyk2 binding
(blot 1 [top], arrows). Pyk2-Y402 failed to bind Src, as expected, and
phosphorylation was barely detectable at this exposure and less dy-
namin bound to Pyk2-Y402 than to wild-type Pyk2. Labels: IP, immu-
noprecipitation; B, Western blot; Dyn, dynamin.
FIG. 6. Dynamin decreases Pyk2 Y881 phosphorylation and Pyk2’s
binding to Grb2. (A) 293VnR cells were transiently cotransfected with
equal amounts of cDNAs encoding Pyk2 and dyn-GFP, dynK44A-
GFP, or empty vector as indicated. Pyk2 was immunoprecipitated,
resolved by SDS-PAGE, and blotted with phospho-specific antibodies
to Pyk2 tyrosine residues Y402, Y579, Y580, and Y881. TCLs were
blotted for Pyk2 or dynamin (GFP) as indicated. (B) 293VnR cells
were cotransfected with Pyk2, dyn-GFP or Grb2-myc as indicated.
Pyk2 was immunoprecipitated and blotted for Grb2 (myc) or dynamin
(GFP). TCLs were blotted to confirm protein expression in these cells.
Representative blots from three independent experiments are shown.
The positions of molecular mass markers are indicated. Labels: IP,
immunoprecipitation; B, Western blot; Dyn, dynamin.
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residues in dynamin-2, coexpressed the dynamin mutants
with Pyk2 in 293VnR cells, and analyzed their effect on Pyk2
phosphorylation and binding. Although both mutants bound
Pyk2, the mutations of the Src-phosphorylated tyrosines, in
particular the Y597F mutation, partially blunted the ability
of dynamin to decrease total Pyk2 phosphorylation and the
phosphorylation of Pyk2 Y402 (Fig. 8), although only a
fraction of the phosphorylation was restored. Thus, the
phosphorylation of dynamin by Src appears to enhance the
dynamin-induced decrease in Pyk2 Y402 phosphorylation
and the resulting decrease in Src’s binding to Pyk2, possibly
by increasing dynamin GTPase activity.
Src acts as an adaptor to mediate the association of dy-
namin and Pyk2. Published studies show that Src’s SH2 do-
main binds Pyk2 phospho-Y402 (16) and suggest that the SH3
domain of Src interacts with dynamin’s C-terminal PRD (25,
27). We therefore sought to determine whether Src’s ability to
act as an adaptor contributed to the dynamin-Pyk2 association
by determining the effects of disabling Src’s SH3 (SrcW118K)
or SH2 (SrcR175L) domains on the association of dynamin
and Pyk2 (Fig. 9). Disabling either of Src’s binding domains
reduced the amount of dynamin that coimmunoprecipitated
with Pyk2 (Fig. 9, blot 2 [i.e., the lower immunoprecipitation
blot], lanes 3 and 5), indicating that Src may indeed act as an
adaptor in the association of dynamin and Pyk2. In the absence
of cotransfected dynamin, both wild-type Src and SrcW118K,
which retains a functional SH2 domain, bound to Pyk2 (Fig. 9,
blot 1 [i.e., the upper blot], lanes 2 and 4), whereas disabling
Src’s SH2 domain eliminated the Pyk2-Src interaction (Fig. 9,
blot 1, lane 6), confirming the known role of Src’s SH2 domain
in binding Pyk2. Furthermore, coexpression of dynamin with
Pyk2 and Src markedly reduced the association of Pyk2 with
both wild-type Src and SrcW118K (Fig. 9, blot 1, lanes 1 and 3),
a finding consistent with the dynamin-induced reduction of the
phosphorylation of Y402 and, thereby, the binding of Src’s
SH2 domain to Pyk2.
Having demonstrated that Src’s adaptor function contrib-
utes to the association of dynamin and Pyk2, we next sought to
identify the dynamin domain involved in the complex forma-
tion. We first tested the reported binding of the Src SH3
domain to the dynamin PRD. We performed far-Western anal-
yses of the binding of a GST-conjugated Src-SH3 domain with
full-length dynamin and a C-terminally truncated dynamin
lacking the PRD (PRD). As shown in Fig. 10A, the Src-SH3
domain bound to dynamin but not to dynPRD, confirming
that Src can bind dynamin’s PRD but not other dynamin do-
mains. Similarly, we confirmed that the Src-SH2 domain re-
quires Pyk2 phospho-Y402 for binding.
We also demonstrated that the PRD was required for the
dynamin-Pyk2 association. Pyk2 was coexpressed with full-
length dynamin, dynPRD, or a dynamin fragment consisting
of only the GED and the PRD (GEDPRD). Pyk2 formed a
complex with full-length dynamin and the GEDPRD frag-
ment but not with dynPRD (Fig. 10B), indicating that the
binding of Src (or possibly another SH3 domain-containing
adaptor protein) to dynamin’s PRD mediates the dynamin-
Pyk2 association.
DISCUSSION
The adhesion, migration, and function of osteoclasts and
other highly motile cells are critically dependent on the proper
assembly, organization and disassembly of podosomes, the dy-
namic integrin- and actin-containing adhesion structures that
characterize such cells (29, 34, 37). We and others have shown
that podosome organization and function in osteoclasts is reg-
FIG. 7. Src promotes dynamin-Pyk2 association and reduced
Pyk2 Y402 phosphorylation. (A) OCLs were generated from Src/
or Src/ mice and lysed in modified radioimmunoprecipitation
assay buffer. Immunoprecipitation of endogenous Pyk2 was per-
formed, followed by Western blotting for endogenous dynamin with
the hudy2 antibody. TCLs were blotted as indicated. Experiments
were performed three times. (B) OCLs were treated with either
dimethyl sulfoxide, PP2 (15 M, 1 h) or SU6656 (10 M, 2 h). Pyk2
was immunoprecipitated and blotted for phosphorylated Y402.
Membranes were stripped and reblotted for Pyk2. Labels: IP, im-
munoprecipitation; B, Western blot; Dyn, dynamin.
FIG. 8. Mutation of dynamin’s Src-phosphorylated tyrosines re-
duces dynamin’s ability to downregulate Pyk2 Y402 phosphorylation.
293VnR cells were cotransfected with Pyk2 and either wild-type dyn-
GFP, the Src phosphorylation site mutants dynY231F-GFP and
dynY597F-GFP, or empty vector as indicated. Pyk2 was immunopre-
cipitated, and the immune complexes were analyzed for Pyk2 by West-
ern blotting. Membranes were stripped and reblotted for phospho-
Y402. Pyk2 was also immunoprecipitated and blotted with dynamin
and Pyk2. TCLs were blotted for transfected dyn-GFP. Experiments
were reproduced four times, and the results of a representative exper-
iment are shown. Labels: IP, immunoprecipitation; B, Western blot;
Dyn, dynamin.
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ulated in part by Src and Pyk2 (15, 18, 26, 31, 35, 40, 50, 65) and
that Src/ osteoclasts fail to form a podosome belt and do not
resorb bone (17, 32, 40, 42, 50, 54). Integrin engagement and
activation induces the formation of a Pyk2-, Src-, and Cbl-
containing signaling complex by the sequential increase in cy-
tosolic free Ca2 levels, activation and autophosphorylation of
Pyk2 at Y402, and recruitment of Src and Src-associated Cbl to
the phosphorylated Pyk2 Y402 (40, 50). Once the complex is
assembled, Src phosphorylates Pyk2 and Cbl on tyrosine resi-
dues, which promotes the binding of other important signaling
elements, such as phosphatidylinositol 3-kinase, Vav, and Grb2
(4, 64). The absence or inhibition of Src decreases the number
of podosomes and the rate of actin flux into existing podo-
somes, while increasing the podosome life span (15). The ab-
sence of Pyk2 similarly decreases the flux of actin into existing
podosomes, but without affecting podosome life span, and pre-
vents the transition of podosome organization from small rings
at the center of the cell to a mature podosome belt at the cell
periphery (26).
Our findings from this and earlier studies indicate that the
GTPase dynamin is also involved in the regulation of podo-
some organization and turnover in osteoclasts, in part by con-
trolling Pyk2’s phosphorylation/dephosphorylation cycle. We
found that dynamin associates with Pyk2, Src and Cbl and
decreases Pyk2 tyrosine phosphorylation in osteoclasts and in
293VnR cells (8; the present study). Whether dynamin pre-
vents Pyk2’s phosphorylation or, alternatively, promotes its
rapid dephosphorylation by activating as-yet-unidentified pro-
tein tyrosine phosphatases (e.g., PTP-PEST [36]) remains to be
determined. However, the prevention of the dynamin-induced
loss of M-CSF-induced Pyk2 phosphorylation by orthovana-
date (Fig. 4C) suggests the latter mechanism. Overexpressing
dynamin-2 also led to the dephosphorylation of FAK at con-
served tyrosine residues (data not shown), which has recently
been reported to also modulate podosome function in osteo-
clasts (48). Thus, the dynamin-mediated regulation of the two
focal adhesion kinases may have broad relevance to mecha-
nisms that control signaling complex assembly/disassembly in
adhesion structures in a variety of cellular types.
The dynamin-induced decrease in Pyk2 Y402 phosphoryla-
tion, in contrast to dynamin’s association with Cbl, appears to
involve the hydrolysis of dynamin-bound GTP. dynK44A,
which binds and hydrolyzes GTP inefficiently (12, 13), binds
Pyk2 at least as much as wild-type dynamin (see Fig. S2 in the
FIG. 9. Src SH2 and SH3 domains mediate the dynamin-Pyk2 as-
sociation. 293VnR cells were cotransfected with Pyk2, dyn-GFP, or
empty vector in combination with either wild-type c-Src or Src mutants
with a disabled SH3 or SH2 domain (SrcW118K and SrcR175L, re-
spectively), as indicated. Immunoprecipitation and Western blots were
performed as indicated. Exogenously expressed Src proteins were de-
tected with an anti-avian Src antibody that does not detect endogenous
Src. Disabling either the SH3 domain or the SH2 domain significantly
reduced the Pyk2-dynamin association (arrows). Molecular mass
markers and the position of IgG band are indicated. Labels: IP, im-
munoprecipitation; B, Western blot; Dyn, dynamin.
FIG. 10. Dynamin’s PRD is required for the dynamin-Pyk2 associ-
ation. (A) 293VnR cells were cotransfected with dynamin, dynPRD,
Pyk2, or Pyk2-Y402F. Dynamin and Pyk2 were immunoprecipitated
and blotted with bacterially expressed GST-Src-SH3 or GST-Src-SH2
fusion proteins, respectively. Blots were stripped and reblotted for
dynamin or Pyk2 as indicated. (B) 293VnR cells were cotransfected
with Pyk2 and either full-length dynamin, dynPRD or dyn(GED
PRD). Pyk2 was immunoprecipitated, and the immune complexes
were analyzed for the presence of the dynamin construct by Western
blotting. The expression of all three dynamin proteins was also con-
firmed by Western blotting. Labels: IP, immunoprecipitation; B, West-
ern blot; Dyn, dynamin.
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supplemental material) but has less of an effect on Pyk2-Y402
dephosphorylation (Fig. 2B). Interestingly, overexpressed
dynK44A reduced the rate of actin flux into formed podo-
somes in v-src-transformed BHK cells (43), similar to what we
observed in osteoclasts that lack Pyk2 (26). We also found that
dynamin’s ability to decrease Pyk2 phosphorylation was par-
tially disabled by mutating either of two tyrosine residues
(Y231 or Y597) in dynamin that are required for the Src-
induced increase in dynamin’s GTPase activity (1, 2), providing
further evidence for a possible role of the Src-regulated dy-
namin GTPase activity in the decrease in Pyk2 phosphoryla-
tion. Although further research will be required to characterize
the mechanism by which GTP hydrolysis promotes Pyk2 de-
phosphorylation, these results suggest that the cycling of dy-
namin between its GTP-bound and GDP-bound states, regu-
lated in part by changes in its phosphorylation state, drives
Pyk2 dephosphorylation, just as it drives endocytosis (1, 2, 6,
12, 13, 56).
The reduction of Pyk2 Y402 phosphorylation by dynamin
exerts a major effect on Pyk2- and Src-dependent signaling. We
confirmed that the dynamin-induced loss of Pyk2 phospho-
Y402 prevents the binding of Src to Pyk2 and, as a result, the
Src-catalyzed phosphorylation of Pyk2 tyrosine residues 579,
580, and 881. The Src-catalyzed phosphorylation of Pyk2 Y579
and Y580 is necessary for maximal Pyk2 catalytic activity (36,
46, 52), and the phosphorylation of Pyk2 Y881 and the result-
ing binding of Grb2 to Pyk2 were decreased when dynamin was
overexpressed. Thus, by inducing Pyk2 Y402 dephosphoryla-
tion and eliminating the Src binding site, dynamin is likely to
both decrease Pyk2’s catalytic activity and antagonize the re-
cruitment of important signaling effectors such as Src, Abl, and
Grb2 (16, 22, 67).
We found that Src regulates dynamin’s association with Pyk2
in OCLs (Fig. 7). In contrast to Src’s destabilizing effect on
dynamin’s association with Cbl (8), both the catalytic activity
and the adaptor function of Src appear to contribute positively
to the dynamin-Pyk2 association and to the dephosphorylation
of Pyk2-Y402. In support of this conclusion, treatment with
either PP2 or SU6656 increased Pyk2-Y402 phosphorylation in
OCLs and decreased dynamin-Pyk2 association in 293VnR
cells. Our findings also suggest that dynamin is a functionally
important target of Src-catalyzed phosphorylation in the sig-
naling complex, since Pyk2 Y402 phosphorylation increased
when dynamin’s Src-phosphorylated tyrosine residues were
mutated (Fig. 8), although we cannot exclude the possibility
that Src-catalyzed phosphorylation of other proteins also con-
tributes to the regulation of dynamin-induced dephosphoryla-
tion of Pyk2 Y402.
In addition to the evidence that Src modulates dynamin-
Pyk2 association and the dephosphorylation of Pyk2 by phos-
phorylating dynamin (and possibly other proteins in the com-
plex), the decrease in dynamin-Pyk2 association observed
when the Src-SH2 or SrcSH3 domain was disabled (Fig. 9),
strongly supports a mechanism in which Src also acts as an
adaptor between dynamin and Pyk2. Far Western analysis
(Fig. 10A) confirmed that Src’s SH2 and SH3 domains bind
directly to Pyk2 and dynamin, respectively. However, our
data show that the SH2-mediated binding of Src to Pyk2 is
not required for the dynamin-Pyk2 association, since Pyk2-
Y402F fails to bind Src but still associates with dynamin
(Fig. 5). Although a mechanism in which Src directly bridges
dynamin and Pyk2 is thus ruled out, a mechanism in which
Src binds indirectly to Pyk2 via one or more other proteins
(24, 30, 44, 49) is supported by our findings. Characterizing
the proteins and intermolecular interactions that mediate
the association of dynamin and Pyk2 will be the focus of
future investigation.
Our results indicate that the Src-modulated downregulation
of Pyk2 phosphorylation by dynamin is an important compo-
nent of the mechanisms that regulate osteoclast activity. The
dynamin-induced decrease in Pyk2 Y402 phosphorylation and
the resulting prevention of Pyk2-Src binding provide an “off-
switch” mechanism for disassembling the Pyk2-Src-Cbl com-
plex and thereby terminating Src-dependent signaling down-
stream of activated Pyk2. Importantly, we showed that
overexpressing dynamin reduced the phosphorylation of Pyk2
that is induced by integrin-mediated adhesion and by M-CSF
treatment (Fig. 4), two stimuli that are key regulators of osteo-
clast function (21), while depleting dynamin increased steady-
state phosphorylation of Pyk2 Y402 and altered the intracel-
lular distribution of Pyk2 and the organization of the
podosome belt (Fig. 3).
The Src-induced promotion of dynamin-Pyk2 association
and the dynamin-induced dephosphorylation of Pyk2 Y402 in
osteoclasts (Fig. 7) suggests the presence of a feedback mech-
anism by which Src that is activated downstream of Pyk2 also
induces the downregulation of Pyk2- and Src-dependent sig-
naling cascades. Thus, Src may be involved in two separate
Pyk2-related functions in the complex: first, coupling activated
Pyk2 to downstream signaling events by binding to Pyk2’s
phosphorylated Y402 and, second, initiating the disassembly of
the Pyk2-Src complex by promoting (and possibly in part me-
diating) the association of dynamin-Pyk2 and the consequent
decrease in Pyk2 phosphorylation. Additional investigation will
be required to confirm this hypothesis and to further elucidate
the molecular mechanism by which Src promotes dynamin’s
modulation of Pyk2 phosphorylation.
In conclusion, we have shown that dynamin associates with
Pyk2 and reduces the phosphorylation of Pyk2 that occurs in
response to functionally important stimuli such as M-CSF and
integrin attachment in osteoclasts, leading to the disruption of
Pyk2-Src binding. In addition, Src promotes the association of
dynamin and Pyk2 and the subsequent loss of phosphorylated
Pyk2 Y402, the site by which Src binds to Pyk2. Thus, dynamin
may provide a Src-dependent “off-switch” that disassembles
the Pyk2-Src-Cbl complex and downregulates its downstream
signaling.
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